Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merrell Dow Pharmaceuticals was a prominent American pharmaceutical company established in 1981 through the merger of the ethical drug business of Richardson-Merrell and the pharmaceutical division of Dow Chemical. Headquartered in Cincinnati, Ohio, the company became a significant player in the global healthcare market, focusing on the development of small molecule therapies across respiratory, cardiovascular, and infectious disease areas. Its portfolio included landmark products such as the non-sedating antihistamine Seldane and the smoking cessation aid Nicorette. In 1989, Dow Chemical merged Merrell Dow with Marion Laboratories to form Marion Merrell Dow, which was later acquired by Hoechst AG. Today, the legacy of Merrell Dow's research and products resides within the global pharmaceutical leader Sanofi.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merrell Dow Pharmaceuticals.